Interpreting declines in HIV test positivity: an analysis of routine data from Zimbabwe's national sex work programme, 2009-2019.
Africa
HIV epidemiology
HIV prevention
key and vulnerable populations
sex workers
testing
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
22
10
2021
accepted:
19
05
2022
entrez:
1
7
2022
pubmed:
2
7
2022
medline:
6
7
2022
Statut:
ppublish
Résumé
Early diagnosis of HIV is critical for epidemic control. To achieve this, successful testing programmes are essential and test positivity is often used as a marker of their performance. The aim of this study was to analyse trends and predictors of HIV test positivity over time and explore how an understanding of seroconversion rates could build on our interpretation of this indicator among female sex workers in Zimbabwe. We analysed HIV test data from Zimbabwe's nationally scaled sex work programme between 2009 and 2019. We defined test positivity as the proportion of all tests that were HIV positive and measured new diagnoses by estimating seroconversion rates among women with repeat tests, defined as an HIV-positive test after at least one HIV-negative test in the programme. We used logistic regression to analyse test positivity over three time-periods: 2009-2013, 2014-2017 and 2018-2019, adjusting for potential confounding by demographic factors and the mediating effects of time since last HIV test. We calculated the seroconversion rates for the same time-periods. During the 10-year study period, 54,503 tests were recorded in 39,462 women. Between 2009 and 2013, 18% of tests were among women who reported testing in the previous 6 months. By 2018-2019, this had increased to 57%. Between 2018 and 2019, test positivity was 9.6%, compared to 47.9% for 2009-2013 (aOR 6.08 95% CI 5.52-6.70) and 18.8% for 2014-2017 (aOR 2.17 95% CI 2.06-2.28). Adjusting for time since last test reduced effect estimates for 2009-2013 (aOR 4.03 95% CI 3.64-4.45) and 2014-2017 (aOR 1.97 95% CI 1.86-2.09) compared to 2018-2019. Among 7573 women with an initial HIV-negative test in the programme and at least one subsequent test, 464 tested HIV positive at a rate of 3.9 per 100 pyar (95% CI 3.5-4.2). Test positivity decreased among women testing through the programme over time, while seroconversion rates remained high. These declines were partly driven by changes in individual testing history, reflecting comprehensive coverage of testing services and greater knowledge of HIV status, but not necessarily declining rates of seroconversion. Understanding testing history and monitoring new HIV infections from repeat tests could strengthen the interpretation of test positivity and provide a better understanding of programme performance.
Identifiants
pubmed: 35773959
doi: 10.1002/jia2.25943
pmc: PMC9247303
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25943Informations de copyright
© 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
AIDS. 2019 Feb 1;33(2):349-352
pubmed: 30557162
Lancet HIV. 2021 May;8(5):e284-e293
pubmed: 33667411
Epidemiology. 2020 Mar;31(2):263-271
pubmed: 31794495
Lancet HIV. 2018 Aug;5(8):e417-e426
pubmed: 30030134
Sci Rep. 2019 Sep 2;9(1):12621
pubmed: 31477764
AIDS. 2021 Feb 2;35(2):317-324
pubmed: 33165030
Curr HIV Res. 2009 Nov;7(6):580-8
pubmed: 19929792
J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):505-512
pubmed: 29697595
PLoS One. 2013 May 23;8(5):e63476
pubmed: 23717432
J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25320
pubmed: 31328445
J Acquir Immune Defic Syndr. 2016 May 1;72(1):e1-8
pubmed: 27093516
AIDS Behav. 2020 Mar;24(3):746-761
pubmed: 31256270
MMWR Morb Mortal Wkly Rep. 2020 Dec 04;69(48):1801-1806
pubmed: 33270608
PLoS One. 2019 Mar 27;14(3):e0212762
pubmed: 30917167
PLoS One. 2013 Apr 16;8(4):e60906
pubmed: 23613753
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
PLoS One. 2019 Dec 27;14(12):e0225877
pubmed: 31881031
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
AIDS. 2019 Dec 15;33 Suppl 3:S295-S302
pubmed: 31805029
BMJ Glob Health. 2021 Apr;6(4):
pubmed: 33906844
AIDS Behav. 2019 Jun;23(6):1494-1507
pubmed: 30788641
PLoS One. 2020 Jun 30;15(6):e0235471
pubmed: 32603374
BMJ Open. 2018 Feb 28;8(2):e018751
pubmed: 29490957
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25244
pubmed: 30907505
J Int AIDS Soc. 2015 Oct 14;18:20182
pubmed: 26471265
Int J Epidemiol. 2018 Feb 1;47(1):236-245
pubmed: 29024978
Curr Opin HIV AIDS. 2015 Nov;10(6):420-9
pubmed: 26352393